Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Restructuring Costs: 2022-2023

Historic Restructuring Costs for Ani Pharmaceuticals (ANIP) over the last 2 years, with Dec 2023 value amounting to $1.1 million.

  • Ani Pharmaceuticals' Restructuring Costs fell 99.92% to $2,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2023, which is 80.07% down from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Restructuring Costs of $1.1 million as of FY2023, which was down 80.07% from $5.7 million recorded in FY2022.
  • Ani Pharmaceuticals' 5-year Restructuring Costs high stood at $5.7 million for FY2022, and its period low was $1.1 million during FY2023.
  • For the 2-year period, Ani Pharmaceuticals' Restructuring Costs averaged around $3.4 million, with its median value being $3.4 million (2022).
  • Data for Ani Pharmaceuticals' Restructuring Costs shows a maximum YoY slumped of 80.07% (in 2023) over the last 5 years.
  • Yearly analysis of 2 years shows Ani Pharmaceuticals' Restructuring Costs stood at $5.7 million in 2022, then plummeted by 80.07% to $1.1 million in 2023.